Kilburn, Lindsay B;
Khuong-Quang, Dong-Anh;
Hansford, Jordan R;
Landi, Daniel;
van der Lugt, Jasper;
Leary, Sarah ES;
Driever, Pablo Hernaiz;
... Nysom, Karsten; + view all
(2025)
The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial (vol 30, pg 207, 2024).
[Corrigendum].
NATURE MEDICINE
, 31
, Article 2454. 10.1038/s41591-025-03709-4.
Preview |
Text
Author Correction The type II RAF inhibitor tovorafenib in relapsedrefractory pediatric low-grade glioma the phase 2 FIREFLY.pdf - Accepted Version Download (645kB) | Preview |
Abstract
Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-023-02668-y, published online 17 November 2023. In the version of the article initially published, the colors in the Fig. 2 key were switched and have now been amended so that teal represents “Prior BRAFi/MEKi” and orange represents “BRAFi/MEKi-naive”. Additionally, in Fig. 2a, the tenth bar from the left was teal and has now been corrected to orange as the patient was BRAFi/MEKi-naive. These corrections have been made to the HTML and PDF versions of the article.
| Type: | Article |
|---|---|
| Title: | The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial (vol 30, pg 207, 2024) |
| Location: | United States |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1038/s41591-025-03709-4 |
| Publisher version: | https://doi.org/10.1038/s41591-025-03709-4 |
| Language: | English |
| Additional information: | This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Developmental Biology and Cancer Dept |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10214535 |
Archive Staff Only
 |
View Item |
